지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.107 No.4
- 발행연도
- 2024.10
- 수록면
- 229 - 236 (8page)
이용수
초록· 키워드
오류제보하기
Purpose: Bariatric surgery is the gold standard for the treatment of morbid obesity, but postoperative pain impedes recovery. Currently available pain-recovery treatments have patient safety concerns. This led to a noninferiority study of Welpass (Genewel Co., Ltd.) vs. On-Q PainBuster (B. Braun), each used alongside a traditional method of continuous local anesthetic administration, in patients undergoing bariatric surgery.
Methods: In this single-center prospective randomized clinical trial, patients were assigned in a 1:1 ratio to the treatment group (Welpass) and the control group (On-Q PainBuster), with ketorolac administered as needed after surgery according to the protocol. To assess efficacy, the total amount of ketorolac used up to 72 hours postoperatively was measured.
Additionally, ketorolac usage and numerical rating scales (NRS) were recorded at 6, 24, 48, and 72 hours after operation.
Results: The total amounts of ketorolac used in the 72 hours postoperatively were 188.0 ± 84.6 mg in the treatment group and 198.7 ± 50.0 mg in the control group. The efficacy of the treatment group was noninferior to that of the control group, since the lower limit (–29.9 mg) of the confidence interval for the difference with the control group was greater than the prespecified noninferiority margin (–35.0 mg). Furthermore, when the NRS was evaluated after bariatric surgery, there was no significant difference in scores between the 2 groups at each time point (P > 0.05).
Conclusion: We found no difference in effect on pain between the 2 groups, supporting the use of Welpass in clinical practice for pain management in patients undergoing bariatric surgery.
Methods: In this single-center prospective randomized clinical trial, patients were assigned in a 1:1 ratio to the treatment group (Welpass) and the control group (On-Q PainBuster), with ketorolac administered as needed after surgery according to the protocol. To assess efficacy, the total amount of ketorolac used up to 72 hours postoperatively was measured.
Additionally, ketorolac usage and numerical rating scales (NRS) were recorded at 6, 24, 48, and 72 hours after operation.
Results: The total amounts of ketorolac used in the 72 hours postoperatively were 188.0 ± 84.6 mg in the treatment group and 198.7 ± 50.0 mg in the control group. The efficacy of the treatment group was noninferior to that of the control group, since the lower limit (–29.9 mg) of the confidence interval for the difference with the control group was greater than the prespecified noninferiority margin (–35.0 mg). Furthermore, when the NRS was evaluated after bariatric surgery, there was no significant difference in scores between the 2 groups at each time point (P > 0.05).
Conclusion: We found no difference in effect on pain between the 2 groups, supporting the use of Welpass in clinical practice for pain management in patients undergoing bariatric surgery.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
ERAS in Bariatric Surgery
대한외과학회 학술대회 초록집
2020 .11
-
Survey of Information Acquisition and Satisfaction after Bariatric Surgery at a Tertiary Hospital in Korea
Journal of Obesity & Metabolic Syndrome
2024 .03
-
k factors for early postoperative complications after bariatric surgery
대한외과학회 학술대회 초록집
2017 .11
-
Laparoendoscopic Single-Site Bariatric Surgery: A Review of Single-Port Laparoscopic and Endoscopic Bariatric Treatments
Journal of Obesity & Metabolic Syndrome
2018 .01
-
Plans to manage the safety of bariatric surgery
대한외과학회 학술대회 초록집
2015 .11
-
Long-term Efficacy of more than 10 Years of Bariatric & Metabolic Surgery
대한외과학회 학술대회 초록집
2021 .11
-
How to Choose the Best Option in Bariatric Surgery?
대한외과학회 학술대회 초록집
2019 .05
-
Korean Hx of Bariatric Surgery
대한외과학회 학술대회 초록집
2018 .11
-
Bariatric & Metabolic Surgery in Patients with Psychological Problems
대한외과학회 학술대회 초록집
2021 .11
-
Bariatric Surgery & Pregnancy
대한외과학회 학술대회 초록집
2021 .11
-
History of Bariatric & Metabolic Surgery
대한외과학회 학술대회 초록집
2021 .11
-
Current Status of Bariatric and Metabolic Surgery in Korea
Endocrinology and Metabolism
2016 .01
-
Short-term outcomes of bariatric surgery: A single center experience
대한외과학회 학술대회 초록집
2019 .10
-
Bariatric & Metabolic Surgery in Adolescents
대한외과학회 학술대회 초록집
2021 .11
-
Long-term effect of bariatric surgery versus conventional therapy in obese Korean patients: a multicenter retrospective cohort study
Annals of Surgical Treatment and Research
2019 .06
-
Weight Loss Prediction after Metabolic and Bariatric Surgery
Journal of Obesity & Metabolic Syndrome
2023 .03
-
Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments
Clinical Endoscopy
2021 .01
-
Review and Case Report of Stomach Cancer Development after Bariatric Surgery
대한외과학회 학술대회 초록집
2017 .11
-
Recent Clinical Results of Endoscopic Bariatric Therapies as an Obesity Intervention
Clinical Endoscopy
2017 .01
-
Bariatric & Metabolic Surgery in Geriatric Patients
대한외과학회 학술대회 초록집
2021 .11
이 논문과 함께 이용한 논문
DNA Aptamer Incorporated PEG Hydrogels for DDS Aplications
박윤슬
,
박민규
,
MATSUMOTO AYANA
외 1명
한국고분자학회 학술대회 연구논문 초록집
2024
.09
Development of Lipid Nano Particles Using Bile Acid and Chondroitin Sulfate for Drug Delivery
전소현
,
박용해
,
김남두
한국고분자학회 학술대회 연구논문 초록집
2024
.09
Immune-Modulating Muti-Functional Protein Nanoparticles for Enhanced Liver Cancer Therapy
A Hyung JEONG
,
Bo
,
am SON
외 1명
한국생물공학회 학술대회
2023
.10
Exosome-mediated delivery of microRNA-497 enhanced the anti-cancer effect
Haneul KIM
,
Kyeongsoo JEONG
,
Jeong Ah KIM
외 1명
한국생물공학회 학술대회
2019
.10
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-25-02-091061487